Bovine surfactant therapy for patients with acute respiratory distress syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 4, 1997, Pages 1309-1315

  Gregory, Timothy J ^b   Steinberg, Kenneth P ^b   Spragg, Roger ^a   Gadek, James E ^b   Hyers, Thomas M ^b   Longmore, William J ^b   Moxley, Michael A ^b   Cai, Guang Zuan ^b   Hite, R Duncan ^b   Smith, Robert M ^b   Hudson, Leonard D ^b   Crim, Courtney ^b   Newton, Pamela ^b   Mitchell, Brian R ^b   Gold, Alan J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID; SURFACTANT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG SCREENING; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; LUNG LAVAGE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL;

EID: 8244231922     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.4.9105072     Document Type: Article

References (25)

1. Bernard, G. R., A. Artigas, K. L. Brigham, J. Carlet, K. Falke, L. Hudson, M. Lamy, R. LeGall, A. Morris, and R. Spragg. 1994. The American-European consensus conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. Rev. Respir. Dis. 149:818-824.
2. Ashbaugh, D. G., D. B. Bigelow, T. L. Petty, and B. E. Levine. 1967. Acute respiratory distress in adults. Lancet 2:319-323.
3. Hallman, M., R. G. Spragg, J. H. Harrell, K. M. Moser, and L. Gluck. 1982. Evidence of lung surfactant abnormality in respiratory failure: study of bronchoalveolar lavage phospholipids, surface activity, phospholipase activity, and plasma myoinositol. J. Clin. Invest. 70:673-683.
4. Pison, U., W. Seeger, R. Buchhorn, T. Joka, M. Brand, U. Obertacke, H. Neuhof, and K. P. Schmit-Neuerburg. 1989. Surfactant abnormalities in patients with respiratory failure after multiple trauma. Am. Rev. Respir. Dis. 140:1033-1039.
5. Pison, U., U. Overtacke, M. Brand, W. Seeger, T. Joka, J. Bruch, and K. P. Schmit-Neuerburg. 1990. Altered pulmonary surfactant in uncomplicated and septicemia-complicated courses of acute respiratory failure. J. Trauma 30:19-26.
6. Gregory, T. J., W. J. Longmore, M. A. Moxley, J. A. Whitsett, C. R. Reed, A. A. I. Fowler, L. D. Hudson, R. J. Maunder, C. Crim, and T. M. Hyers. 1991. Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J. Clin. Invest. 88:1976-1981.
7. Lewis, J. F., and A. H. Jobe. 1993. Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147:218-233.
8. Merritt, T. A., C. G. Cochrane, K. Holcomb, B. Bohl, M. Hallman, D. Strayer, D. K. Edwards, and L. Gluck. 1983. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome: role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J. Clin. Invest. 72:656-666.
9. Lachmann, B. 1987. The role of pulmonary surfactant in the pathogenesis and therapy of ARDS. In J. L. Vincent, editor. Update in Intensive Care and Emergency Medicine. Springer, New York. 123-134.
10. Spragg, R. G., N. Gilliard, P. Richman, R. M. Smith, R. D. Hite, D. Pappert, B. Robertson, T. Curstedt, and D. Strayer. 1994. Acute effects of a single dose of porcine surfactant on patients with the adult respiratory distress syndrome. Chest 105:195-202.
11. Nosaka, S., T. Sakai, M. Yonekura, and K. Yoshikawa. 1990. Surfactant for adults with respiratory failure. Lancet 336:947-948.
12. Walmrath, D., A. Günther, H. A. Ghofrani, R. Schermuly, T. Schneider, F. Grimminger, and W. Seeger. 1996. Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis. Am. J. Respir. Crit. Care Med. 154:57-62.
13. Willson, D. F., J. H. Jiao, L. A. Bauman, A. Zaritsky, H. Craft, K. Dockery, D. Conrad, and H. Dalton. 1996. Calf's lung surfactant extract in acute hypoxemic respiratory failure in children. Crit. Care Med. 24:1316-1322.
14. Anzueto, A., R. Baughman, K. K. Guntupalli, J. G. Weg, H. P. Wiedemann, A. A. Raventos, F. Lemaire, W. Long, D. S. Zaccardelli, and E. N. Pattishall. 1996. Aerosolized surfactants in adults with sepsis-induced acute respiratory distress syndrome. N. Engl. J. Med. 334: 1417-1421.
15. Lamm, W. J., and R. K. Albert. 1990. Surfactant replacement improves lung recoil in rabbit lungs after acid aspiration. Am. Rev. Respir. Dis. 142:1279-1283.
16. Harris, J. D., F. J. Jackson, M. A. Moxley, and W. J. Longmore. 1989. Effect of exogenous surfactant instillation on experimental acute lung injury. J. Appl. Physiol. 66:1846-1851.
17. Anderson, B. M., F. J. Jackson, M. A. Moxley, and W. J. Longmore. 1992. Effects on experimental acute lung injury 24 hours after exogenous surfactant instillation. Exp. Lung Res. 18:191-204.
18. Hoekstra, R. E., J. C. Jackson, T. F. Myers, I. D. Frantz, M. E. Stern, W. F. Powers, M. Maurer, J. R. Raye, S. T. Carrier, and J. H. Gunkel. 1991. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Pediatrics 88:10-18.
19. Liechty, E. A., E. Donovan, D. Purohit, J. Gilhooly, B. Feldman, A. Noguchi, S. E. Denson, S. S. Sehgal, I. Gross, and D. Stevens. 1991. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics 88:19-28.
20. Zola, E. M., A. M. Overbach, J. H. Gunkel, B. R. Mitchell, B. T. Nagle, N. G. DeMarco, G. A. Henwood, and A. J. Gold. 1993. Treatment Investigational New Drug experience with Survanta (beractant). Pediatrics 91:546-551.
21. Survanta Multidose Study Group. 1994. Two-year follow-up of infants treated for neonatal respiratory distress syndrome with bovine surfactant. J. Pediatr. 124:962-967.
22. Yu, S. H., and F. Possmayer. 1988. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant. Biochim. Biophys. Acta 961:337-350.
23. Milberg, J. A., D. R. Davis, K. P. Steinberg, and L. D. Hudson. 1995. Improved survival of patients with acute respiratory distress syndrome (ARDS): 1983-1993. J.A.M.A. 273:306-309.
24. Lachmann, B. 1987. B. Lachmann, editor. Surfactant replacement in acute respiratory failure: animal studies and first clinical trials. In Surfactant Replacement Therapy. Springer-Verlag, New York. 212-223.
25. Gilliard, N., G. P. Heldt, J. Loredo, H. Gasser, H. Redl, T. A. Merritt, and R. G. Spragg. 1994. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters tension properties. J. Clin. Invest. 93:2608-2615.